185750.KS Chong Kun Dang Pharmaceutical Corp.
KSCHealthcareAs of 2026-08-09 03:23
Why 185750.KS matters now
Chong Kun Dang Pharmaceutical Corp. (185750.KS) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩70,500.00 with +2.47% on the session and ₩973.10B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 12.12, gross margin 21.3%, and operating margin 4.4%.
Valuation
P/E (TTM)
12.12
PEG
—
P/B
0.95
P/S
0.52
EV/EBITDA
9.87
DCF Value
—
FCF Yield
-12.1%
Div Yield
0.7%
Margins & Returns
Gross Margin
21.3%
Operating Margin
4.4%
Net Margin
4.4%
ROE
8.0%
ROA
4.2%
ROIC
5.3%
Listing Info
Market
Korea
Exchange
KSC
Currency
KRW
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
KR
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.